Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
tesa is a global leader in adhesive technologies, operating a specialized pharmaceutical division that focuses on advanced drug delivery systems. The company serves as a Contract Development and Manufacturing Organization (CDMO) specializing in transdermal therapeutic systems (TTS) and oral dissolvable films (ODF). tesa provides end-to-end services ranging from early-stage formulation and clinical trial supply to full-scale commercial production. Their technology platforms enable the controlled release of active pharmaceutical ingredients through the skin or oral mucosa, improving patient compliance and therapeutic outcomes. Additionally, tesa produces high-performance medical adhesives and tapes for wound care and wearable diagnostic devices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on tesa.